Milestone Pharmaceuticals Inc. (MIST) stock
MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.52−0.14 (-20.63%)
Close on Nov 13, 2026Market cap $64.74MP/E –Yield –
Milestone Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Milestone Pharmaceuticals's cash was $145.40M at Sep 30, 2026. For fiscal 2025 it was $106.00M, up 52.1% from the year before. The highest annual figure on record is $142.30M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $106.00M | +52.1% |
| FY2024 | Dec 31, 2024 | $69.70M | +5.6% |
| FY2023 | Dec 31, 2023 | $66.00M | +2.3% |
| FY2022 | Dec 31, 2022 | $64.50M | -43.5% |
| FY2021 | Dec 31, 2021 | $114.10M | -19.8% |
| FY2020 | Dec 31, 2020 | $142.30M | +18.8% |
| FY2019 | Dec 31, 2019 | $119.82M | +39.4% |
| FY2018 | Dec 31, 2018 | $85.98M | +690.2% |
| FY2017 | Dec 31, 2017 | $10.88M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $145.40M | +76.0% |
| Q2 FY2026 | Jun 30, 2026 | $170.60M | +293.1% |
| Q1 FY2026 | Mar 31, 2026 | $184.20M | +228.9% |
| Q4 FY2025 | Dec 31, 2025 | $106.00M | +52.1% |
| Q3 FY2025 | Sep 30, 2025 | $82.60M | +8.1% |
| Q2 FY2025 | Jun 30, 2025 | $43.40M | -47.9% |
| Q1 FY2025 | Mar 31, 2025 | $56.00M | -37.4% |
| Q4 FY2024 | Dec 31, 2024 | $69.70M | +5.6% |
| Q3 FY2024 | Sep 30, 2024 | $76.40M | +0.9% |
| Q2 FY2024 | Jun 30, 2024 | $83.30M | -4.9% |
| Q1 FY2024 | Mar 31, 2024 | $89.50M | -11.4% |
| Q4 FY2023 | Dec 31, 2023 | $66.00M | +2.3% |
| Q3 FY2023 | Sep 30, 2023 | $75.70M | -1.9% |
| Q2 FY2023 | Jun 30, 2023 | $87.60M | +1.6% |
| Q1 FY2023 | Mar 31, 2023 | $101.00M | +0.8% |
| Q4 FY2022 | Dec 31, 2022 | $64.50M | -43.5% |
| Q3 FY2022 | Sep 30, 2022 | $77.20M | -38.9% |
| Q2 FY2022 | Jun 30, 2022 | $86.20M | -36.5% |
| Q1 FY2022 | Mar 31, 2022 | $100.20M | -22.9% |
| Q4 FY2021 | Dec 31, 2021 | $114.10M | -19.8% |
| Q3 FY2021 | Sep 30, 2021 | $126.40M | +22.8% |
| Q2 FY2021 | Jun 30, 2021 | $135.80M | +59.0% |
| Q1 FY2021 | Mar 31, 2021 | $129.90M | +27.6% |
| Q4 FY2020 | Dec 31, 2020 | $142.30M | +18.8% |
| Q3 FY2020 | Sep 30, 2020 | $102.90M | -24.6% |
| Q2 FY2020 | Jun 30, 2020 | $85.40M | -41.4% |
| Q1 FY2020 | Mar 31, 2020 | $101.82M | +42.9% |
| Q4 FY2019 | Dec 31, 2019 | $119.82M | +39.4% |
| Q3 FY2019 | Sep 30, 2019 | $136.50M | +3153.9% |
| Q2 FY2019 | Jun 30, 2019 | $145.82M | +719.1% |
| Q1 FY2019 | Mar 31, 2019 | $71.27M | +440.6% |
| Q4 FY2018 | Dec 31, 2018 | $85.98M | +690.2% |
| Q3 FY2018 | Sep 30, 2018 | $4.20M | – |
| Q2 FY2018 | Jun 30, 2018 | $17.80M | – |
| Q1 FY2018 | Mar 31, 2018 | $13.18M | – |
| Q4 FY2017 | Dec 31, 2017 | $10.88M | – |
See a number that looks wrong?